Abstract

Background: Previous studies suggested that urine albumin excretion in the high normal range predicts hypertension. However, this still remains unclear in the Japanese general population. Aim: To clarify the relationship between the levels of urinary albumin-creatinine ratio (UACR) and incident hypertension among subjects without diabetes and renal insufficiency. Methods: We conducted a cohort study of 459 normotensives without diabetes and renal insufficiency (eGFR ≤60 ml/min/1.73m2) in a community-based study in Japan and followed for 7 years (median 6.7 years). We examined the incidence of hypertension depending on the UACR levels at baseline. The incident hypertension was defined as new onset of systolic blood pressure ≥140 mmHg or diastolic blood pressure ≥90 mmHg or taking any anti-hypertensive drugs. Results: During follow-up period, 256 subjects (55.8%) developed hypertension. The incidence of hypertension was increased along with the increase in UACR at baseline (41.5% in UACR <5mg/g, 59.1% in 5-14 mg/g and 66.0% in 15-29 mg/g, P<0.05). Multivariate logistic regression analysis after adjustment with age, sex, obesity, smoking status, alcohol consumption, and estimated 24-hour urinary excretion of sodium showed that UACR 5-14 mg/g and 15-29 mg/g were independent risk for incident hypertension, compared with UACR <5 mg/g (odds ratio [OR] 1.99, 95% confidence interval [CI] 1.20-3.30 and OR 2.12, 95% CI 1.01-4.54, respectively). Subgroup analysis showed that UACR 5-29 mg/g was a significant risk for incident hypertension compared with UACR <5 mg/g, especially in the subjects conventionally regarded as low risk, such as women, young (<60 years), non-obese, non-smoker, no habitual drinker, and subjects on low sodium diet (NaCl <10 g/day). Conclusions: This study showed that a slight increase of urinary albumin excretion might predict incident hypertension in the Japanese general population, especially in the subjects conventionally regarded as low risk group.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call